Capricor Therapeutics (CAPR) Return on Assets (2011 - 2026)

Capricor Therapeutics' Return on Assets history runs 16 years deep, the most recent figure standing at 0.01% for Q1 2026.

• On a quarterly basis, Return on Assets rose 1.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Assets climbed to 0.01% in Q1 2026 per CAPR's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.01% in Q1 2022 and bottomed at 0.03% in Q3 2024.
• The 5-year median for Return on Assets is 0.01% (2023), against an average of 0.01%.
• Across the five-year window, Return on Assets decreased 2 bps in 2024 and climbed 2 bps in 2025, its largest moves.
• Year by year, Return on Assets stood at 0.01% in 2022, then rose by 16 bps to 0.01% in 2023, then sank by 86 bps to 0.02% in 2024, then jumped by 45 bps to 0.01% in 2025, then grew by 26 bps to 0.01% in 2026.
• Per Business Quant, the three latest CAPR Return on Assets figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).